Soleno Therapeutics (SLNO) Net Cash Flow Growth (1y) (2014 - 2026)
Soleno Therapeutics (SLNO) Net Cash Flow Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -88.82% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 301.06% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 453.08% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -125.22% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn | 1,053.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,053.77% |
| Dec 31, 2025 | -546.80% |
| Sep 30, 2025 | 2,076.60% |
| Jun 30, 2025 | -134.38% |
| Mar 31, 2025 | 94.80% |
| Dec 31, 2024 | -66.30% |
| Sep 30, 2024 | -126.04% |
| Jun 30, 2024 | 23.34% |
| Mar 31, 2024 | -1,785.17% |
| Dec 31, 2023 | 2,377.02% |
| Sep 30, 2023 | 866.55% |
| Jun 30, 2023 | 334.48% |
| Mar 31, 2023 | -187.72% |
| Dec 31, 2022 | 25.17% |
| Sep 30, 2022 | 20.27% |
| Jun 30, 2022 | 38.81% |
| Mar 31, 2022 | 200.70% |
| Dec 31, 2021 | 0.46% |
| Sep 30, 2021 | 14.91% |
| Jun 30, 2021 | -116.89% |